MedPath

The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children

Phase 2
Completed
Conditions
HIV Infections
Registration Number
NCT00000983
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

To evaluate and compare differences in tolerance and side effects associated with two different dosages of zidovudine (AZT) when used to treat children with HIV infection. Other goals are to evaluate and compare the degree of change in neurodevelopmental disease and determine whether there are differences in the rate and degree of toxicities associated with one versus the other dosage.

AZT has been shown to decrease the death rate and frequency of opportunistic infections in certain adult patients with symptomatic HIV infection. Thus, it is likely that symptomatic HIV infected children may also benefit from AZT. Studies of the safety and pharmacokinetics (blood levels) in children have indicated that AZT can be given to children in doses that can be tolerated and that can be assumed to be therapeutic. Those currently taking care of infected children no longer feel it is ethical to conduct an AZT/placebo (inactive substance) trial. In addition, given the information learned from studies of adult patients that shows effectiveness of AZT at lower doses, experience with an equivalent lower dose in children needs to be studied.

Detailed Description

AZT has been shown to decrease the death rate and frequency of opportunistic infections in certain adult patients with symptomatic HIV infection. Thus, it is likely that symptomatic HIV infected children may also benefit from AZT. Studies of the safety and pharmacokinetics (blood levels) in children have indicated that AZT can be given to children in doses that can be tolerated and that can be assumed to be therapeutic. Those currently taking care of infected children no longer feel it is ethical to conduct an AZT/placebo (inactive substance) trial. In addition, given the information learned from studies of adult patients that shows effectiveness of AZT at lower doses, experience with an equivalent lower dose in children needs to be studied.

All participants are randomized to receive AZT at 1 of 2 doses. Patients are stratified according to whether CD4 cell counts are \> or \< 500 cells/mm3 as well as whether symptoms are mild to moderate or if patients have lymphocytic interstitial pneumonitis (LIP). Medication is dispensed every other week for the first 8 weeks and monthly until week 104, then either monthly or every 3 months. Safety and effectiveness of the treatment program are evaluated at 6-month intervals to assess whether it is appropriate to continue the study as originally designed. Patients are evaluated every 2 weeks for the first 8 weeks, monthly until week 104, every 3 months until week 208, and then every 6 months thereafter.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (51)

UCLA Med Ctr / Pediatric

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Children's Hosp of Los Angeles/UCLA Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Cedars Sinai / UCLA Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Emory Univ School of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Atlanta, Georgia, United States

Univ of Maryland at Baltimore / Univ Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Baltimore, Maryland, United States

Johns Hopkins Hosp - Pediatric

๐Ÿ‡บ๐Ÿ‡ธ

Baltimore, Maryland, United States

Cook County Hosp

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Univ of Illinois College of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Chicago Children's Memorial Hosp

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Children's Hosp of Boston

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Boston Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Hermann Hosp / Univ Texas Health Science Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

Univ of California / San Diego Treatment Ctr

๐Ÿ‡บ๐Ÿ‡ธ

San Diego, California, United States

Univ of Miami School of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

Duke Univ Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Durham, North Carolina, United States

Univ of Connecticut Health Ctr / Pediatrics

๐Ÿ‡บ๐Ÿ‡ธ

Farmington, Connecticut, United States

Children's Natl Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Washington, District of Columbia, United States

UPR Children's Hosp / San Juan City Hosp

๐Ÿ‡ต๐Ÿ‡ท

San Juan, Puerto Rico

Univ of North Carolina

๐Ÿ‡บ๐Ÿ‡ธ

Chapel Hill, North Carolina, United States

Columbus Children's Hosp

๐Ÿ‡บ๐Ÿ‡ธ

Columbus, Ohio, United States

Julio Arroyo

๐Ÿ‡บ๐Ÿ‡ธ

West Columbia, South Carolina, United States

Ramon Ruiz Arnau Univ Hosp / Pediatrics

๐Ÿ‡ต๐Ÿ‡ท

Bayamon, Puerto Rico

San Juan City Hosp

๐Ÿ‡ต๐Ÿ‡ท

San Juan, Puerto Rico

Holmes Hosp / Univ of Cincinnati Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Cincinnati, Ohio, United States

SUNY / Health Sciences Ctr at Brooklyn / Pediatrics

๐Ÿ‡บ๐Ÿ‡ธ

Brooklyn, New York, United States

Saint Luke's - Roosevelt Hosp Ctr

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Mount Sinai Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Columbia Univ Babies' Hosp

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Bowman Gray School of Medicine / North Carolina Baptist Hosp

๐Ÿ‡บ๐Ÿ‡ธ

Winston-Salem, North Carolina, United States

Hemophilia Ctr of Western PA / Univ of Pittsburgh

๐Ÿ‡บ๐Ÿ‡ธ

Pittsburgh, Pennsylvania, United States

Bellevue Hosp / New York Univ Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Schneider Children's Hosp / Long Island Jewish Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

New Hyde Park, New York, United States

Univ of Rochester Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, New York, United States

Los Angeles County - USC Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Harlem Hosp Ctr

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Beth Israel Med Ctr / Pediatrics

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Jewish Hosp Ctr of Long Island / Pediatrics

๐Ÿ‡บ๐Ÿ‡ธ

Jamaica, New York, United States

Cornell Univ Med College

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Westchester Hosp / New York Med College / Pediatrics

๐Ÿ‡บ๐Ÿ‡ธ

Valhalla, New York, United States

Metropolitan Hosp Ctr

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Texas Children's Hosp / Baylor Univ

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

Ctr for Special Immunology

๐Ÿ‡บ๐Ÿ‡ธ

Fort Lauderdale, Florida, United States

Kaiser Permanente / UCLA Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Downey, California, United States

Northern California Pediatric AIDS Treatment Ctr / UCSF

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco, California, United States

Children's Hosp of Oakland

๐Ÿ‡บ๐Ÿ‡ธ

Oakland, California, United States

Univ of Massachusetts Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Worcester, Massachusetts, United States

Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl

๐Ÿ‡บ๐Ÿ‡ธ

Newark, New Jersey, United States

Albert Einstein College of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Bronx, New York, United States

Lincoln Hosp Ctr / Pediatrics

๐Ÿ‡บ๐Ÿ‡ธ

Bronx, New York, United States

Bronx Lebanon Hosp Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Bronx, New York, United States

Long Beach Memorial (Pediatric)

๐Ÿ‡บ๐Ÿ‡ธ

Long Beach, California, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath